Cloonan Michael Insider Trades

Insider Trading History

Track insider trading activity for Cloonan Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bluebird bio
Bluebird bio BLUE
Director
Holding Value $0 0 shares
Last Trade
Jun 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.28k 1,867 shares
$4.97
$4.97
Bluebird bio
Bluebird bio BLUE
Director
Holding Value $186k 37,350 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$388k 37,350 shares
$10.39
$4.97
Bluebird bio
Bluebird bio BLUE
Director
Holding Value $372k 74,775 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 74,775 shares
$17.07
$4.97
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $165k 19,000 shares
Last Trade
Feb 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 19,000 shares
$82.27
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $434k 50,000 shares
Last Trade
May 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.86M 50,000 shares
$37.13
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $82k 9,450 shares
Last Trade
Apr 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$377k 9,450 shares
$39.87
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $195k 22,500 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 22,500 shares
$68.87
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director, Chief Business Officer
Holding Value $18.2k 2,102 shares
Last Trade
Jul 25, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$176k 1,088 shares
$161.38
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director, Chief Business Officer
Holding Value $27.7k 3,190 shares
Last Trade
Jul 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 2,450 shares
$161.38
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $221k 25,461 shares
Last Trade
May 22, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.4M 25,000 shares
$175.95
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $4k 461 shares
Last Trade
May 22, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.38M 25,000 shares
$175.00
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $1.39M 160,000 shares
Last Trade
May 22, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.4M 25,000 shares
$175.95
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $213k 24,500 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.86M 24,500 shares
$157.63
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $312k 36,000 shares
Last Trade
Apr 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 72,000 shares
$145.77
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Chief Business Officer
Holding Value $1.61M 185,000 shares
Last Trade
May 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.6M 185,000 shares
$73.43
$8.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up